A surprising 15% reduction in all-cause mortality over 2.8 years was observed in individuals taking metformin, despite their diabetes. This raises intriguing questions about metformin's potential benefits beyond blood glucose control, suggesting it may play a role in reducing inflammation and other age-related factors. The discussion highlights the need for further exploration into the mechanisms behind these findings.
